“Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2 and CIMPACT)” (2020) SKIN The Journal of Cutaneous Medicine, 4(5), p. s45. doi:10.25251/skin.4.supp.45.